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Prokaryotes use a mechanism called priming to up-
date their CRISPR immunological memory to rapidly
counter revisiting, mutated viruses, and plasmids.
Here we have determined how new spacers are
produced and selected for integration into the
CRISPR array during priming. We show that Cas3
couples CRISPR interference to adaptation by pro-
ducing DNA breakdown products that fuel the spacer
integration process in a two-step, PAM-associated
manner. The helicase-nuclease Cas3 pre-processes
target DNA into fragments of about 30–100 nt en-
riched for thymine-stretches in their 30 ends. The
Cas1-2 complex further processes these fragments
and integrates them sequence-specifically into
CRISPR repeats by coupling of a 30 cytosine of the
fragment. Our results highlight that the selection of
PAM-compliant spacers during priming is enhanced
by the combined sequence specificities of Cas3 and
the Cas1-2 complex, leading to an increased propen-
sity of integrating functional CTT-containing spacers.
INTRODUCTION
Priming is a mechanism by which immune systems provide an
improved immune response to parasite exposure. In verte-
brates, priming of adaptive immunity can occur upon first con-
tact of a T or B cell with a specific antigen and causes epigenetic
changes as well as cell differentiation into effector T or B cells,
producing high levels of antibodies (Bevington et al., 2016).
More recently, immune priming has been observed in inverte-
brates, where it provides increased resistance to previously
encountered pathogens (Kurtz and Franz, 2003; Schmid-Hem-
pel, 2005). In plants, priming refers to a state in which the plant
can activate its defense responses more rapidly and strongly
when challenged by pathogenic microbes, insects, or environ-
mental stress (Conrath et al., 2015). In microbes, priming is a
mechanism in which cells can update their immunological
memory to provide protection against previously encountered852 Molecular Cell 63, 852–864, September 1, 2016 ª 2016 Elsevierbut slightly changed viruses or conjugative plasmids (Datsenko
et al., 2012; Li et al., 2014; Richter et al., 2014; Swarts et al.,
2012; Vorontsova et al., 2015). Microbial adaptive immune sys-
tems do this by integrating short fragments of invader DNA se-
quences (called spacers) into clusters of regularly interspaced
short palindromic repeats (CRISPR). These spacers are tran-
scribed and processed into small CRISPR RNAs (crRNAs) and
guide Cas (CRISPR-associated) surveillance complexes such
as Cascade, Cas9, Cpf1, Csm, and Cmr to their DNA or RNA
target sequences, resulting in target cleavage and neutraliza-
tion of the invading threat (Carter and Wiedenheft, 2015; Char-
pentier et al., 2015; Makarova et al., 2015; Marraffini, 2015;
Reeks et al., 2013).
For many years, the acquisition of new spacers was the least
understood process in CRISPR-Cas defense, but recent ad-
vances have begun to change this (Amitai and Sorek, 2016; Fi-
neran and Charpentier, 2012; Heler et al., 2014; Sternberg
et al., 2016). In the type I-E system of E. coli, Cas1 and Cas2
form a complex that binds, processes, and integrates DNA frag-
ments into the CRISPR array to form spacers (Arslan et al., 2014;
Nun˜ez et al., 2014, 2015b; Rollie et al., 2015; Wang et al., 2015).
Apart from priming, spacers can also be acquired in a naive
manner. During naive acquisition, the host acquires spacers
from an invading DNA element that has not been cataloged in
the CRISPR array yet. This process is dependent on DNA repli-
cation of the invading DNA element (Levy et al., 2015) and re-
quires only cas1 and cas2 genes (Yosef et al., 2012). In type I
CRISPR-Cas systems, primed acquisition makes use of pre-ex-
isting spacers that partially match an invading DNA element.
Therefore, primed acquisition of spacers is important to rapidly
counter invaders that escape immunity by mutating their target
site (Cady et al., 2012; Datsenko et al., 2012; Fineran et al.,
2014; Semenova et al., 2011; Xue et al., 2015). Priming allows
new spacers from such an ‘‘escaper’’ to be rapidly acquired,
leading to renewed immunity. Priming is especially advanta-
geous for a host because the process quickly generates a pop-
ulation of bacteria with different spacers against the same virus,
efficiently driving the virus extinct (van Houte et al., 2016). In
addition to Cas1-2, all remaining Cas proteins are required for
priming, including the crRNA effector complex Cascade and
the nuclease-helicase Cas3 (Datsenko et al., 2012; Richter
et al., 2014). Although the genetic requirements for priming are
known, the exact role of these proteins during priming remainsInc.
unknown. Several models that explain parts of the priming pro-
cess have been proposed.
In the Cascade-sliding model, Cascade moves along the DNA
until a protospacer-adjacent motif (PAM) is encountered, which
marks the DNA for acquisition of a new spacer (Datsenko
et al., 2012). A second model was proposed in which a Cas1:
Cas2-3 complex translocates away from the primed protospacer
marked by the crRNA-effector complex until a new PAM is
encountered (Richter et al., 2014). A new spacer is then acquired
from this new PAM site. Recently, supporting evidence for this
hypothesis has been obtained. Single-molecule studies have
suggested that Cascade bound to a priming protospacer re-
cruits Cas1-2, which in turn recruit a nuclease inactive Cas3
(Redding et al., 2015). A complex of Cas1-3may then translocate
along the DNA to select new spacers. Although these models
describe the biochemistry and movement of the proteins
involved in priming, it has remained unknown how actual DNA
fragments from an invading element are obtained to drive the
priming process. We have previously put forward a model in
which we propose that DNA breakdown products of Cas3 pro-
vide the positive feedback needed to fuel the priming process
(Swarts et al., 2012). Similar models were proposed for priming
in I-B and I-F systems (Li et al., 2014; Vorontsova et al., 2015).
In line with that hypothesis, it has recently been suggested that
during naive acquisition, spacer precursors are generated during
DNA repair at double-stranded breaks (Levy et al., 2015). These
breaks are frequently formed at stalled replication forks during
DNA replication and are repaired by the RecBCD complex.
RecBCD unwinds the DNA strands with its helicase activity,
while degrading the subsequent single-stranded stretches using
exonuclease activity. The resulting DNA oligomers have been
proposed to form precursors for Cas1-2 to produce new
spacers. Similar to RecBCD, Cas3 is also a nuclease-helicase
that degrades double-stranded DNA (dsDNA) by unwinding,
with the difference that Cas3 has been shown to degrade one
strand at a time (Gong et al., 2014; Huo et al., 2014; Mulepati
and Bailey, 2013; Sinkunas et al., 2013; Westra et al., 2012).
This leads to the hypothesis that Cas3 also produces substrates
for Cas1-2 mediated spacer acquisition during priming.
Here we have tested that hypothesis and prove that plasmid
degradation products produced by Cas3 are bound by the
Cas1-2 complex, processed into new spacers and integrated
into the CRISPR array. The cleavage frequency and cleavage
specificity of Cas3 facilitate the production of functional spacer
precursor molecules that meet all requirements of new spacers.
To achieve this, Cas3 produces fragments that are in the range of
the length of a spacer (30–100 nt). Furthermore, the cleavage
specificity of Cas3 leads to an enrichment of PAM sequences
in the 30 end of these fragments, which enhances the selection
of productive spacer precursors by Cas1-2. Our results demon-
strate that the DNA degradation fragments produced by Cas3
are the direct link between CRISPR interference and adaptation
that make the priming mechanism so robust.
RESULTS
Previous studies have shown that direct interference in type I
CRISPR-Cas systems (i.e. the breakdown of Cascade-flaggedinvading DNA by Cas3) is relatively sensitive to mutations in
the PAM and seed sequence of the protospacer (Ku¨nne et al.,
2014; Semenova et al., 2011; Wiedenheft et al., 2011; Xue
et al., 2015). Priming on the other hand is an extremely robust
process capable of dealing with highly mutated targets with up
to 13mutations. Priming is influenced by a complex combination
of the number of mutations in a target, the position of these mu-
tations, and the nucleotide identity of the mutation. Furthermore,
the degree of tolerance of mutations in a protospacer during
interference and priming depends on the spacer choice (Xue
et al., 2015).
Timing of Plasmid Loss and Spacer Acquisition Reveals
Distinct Underlying Processes
In order to find the molecular explanation for why some mu-
tants with equal numbers of mutations show priming while
others do not, we performed detailed analysis of a selected
set of target mutants obtained previously (Fineran et al.,
2014). From the available list, we chose the bona fide target
(WT) and 30 mutants carrying an interference permissive
PAM (i.e. 50-CTT-30). The mutants had between 2 and 5 effec-
tive mutations (i.e., mutations outside the kinked positions 6,
12, 18, 24, and 30; Fineran et al., 2014; Jackson et al.,
2014; Mulepati et al., 2014; Zhao et al., 2014) (Figure S1).
We used E. coli strain KD263 with inducible expression of
cas3 and cascade-cas1-2 genes (Shmakov et al., 2014) to
test both direct interference and priming in a plasmid loss
setup. Plasmid loss curves of individual mutants (Figure S2)
showed four distinct behaviors that led us to classify these
target mutants into four groups: mutants capable of only direct
interference (D+P), mutants capable of direct interference
and priming (D+P+), mutants capable of only priming (DP+),
and mutants incapable of both direct interference and priming
(DP) (Figures 1A and 1B). As expected, rapid plasmid loss
was observed for the bona fide target, but also for five mutant
targets. These target variants (D+P) showed plasmid loss
within 2 hr post-induction (hpi), reaching complete loss after
3 hpi (Figure 1B, bottom left cluster), and did not incorporate
new spacers. The D+P+ group of mutants showed a slower
decrease in plasmid abundance (starting at 3 hpi), and this
decrease was accompanied by the incorporation of new
spacers 4 hpi (Figure 1B, bottom right cluster). The DP+
group of mutants showed more strongly delayed plasmid
loss (>5 hpi), and this loss was preceded or directly accompa-
nied by spacer acquisition (Figure 1B, top right cluster). There-
fore, these mutants could not be cleared from the cells by
direct interference initially, but after primed spacer acquisition,
the plasmid was rapidly lost. No spacer incorporation was
observed for DP targets, and these variants did not show
any plasmid loss within 48 hpi, similar to a non-target plasmid
(Figure 1B, top left cluster). This group exemplifies that no
naive acquisition had occurred within 48 hr in our experimental
setup and that all spacer integration events observed in P+
groups were due to priming. To validate that spacer acquisi-
tion occurred by priming, we sequenced the newly incorpo-
rated spacers for a representative set of clones, especially
including mutants with late acquisition. We did indeed observe
the 9:1 strand bias of new spacers that is typical for primingMolecular Cell 63, 852–864, September 1, 2016 853
0h 1h 2h 3h 4h 5h 24
h
0
50
100
D+P-
D+P+
D-P+
D-P-
Hours post induction
Pl
as
m
id
re
te
nt
io
n 
[%
]
D+P- D+P+
D-P+ D-P-
Spacer acquisition
0     1     2      3     4     5    24       0    1     2     3      4     5    24
A B
No
sp
ac
er 1h 2h 3h 4h 5h 24
h
0
1
2
3
4
5
24
No loss
New Spacers after:
St
ar
to
fp
l a
sm
id
lo
s s
[ h
]
D+P-
D+P+
D-P+
D-P-
M1, M2, M3 
M8
WT, M5
M4, M7, M9
M10, M12
M6
M13, M18, M19, M20
M22, M26, M29, M30
M14, M16
 M17, M21 
M23, M25
M27, M28
M11 M24
M15
W
T NT M1 M2 M3 M4 M5 M6 M7 M8 M9 M1
0
M1
1
M1
2
M1
3
M1
4
M1
5
M1
6
M1
7
M1
8
M1
9
M2
0
M2
1
M2
2
M2
3
M2
4
M2
5
M2
6
M2
7
M2
8
M2
9
M3
0
1/1024
1/512
1/256
1/128
1/64
1/32
1/16
1/8
1/4
1/2
1
2
4
R
el
at
iv
e
tra
ns
fo
r m
at
io
n
ef
fic
ie
nc
y 
(fo
ld
 c
ha
ng
e)
D+P-
D+P+
D-P+
D-P-
C
1
32
1
32
3 2 2 2 3 2 3 3 2 3 34 5 2 4
3 3 5 5 5 4 5 3 3 4 3 3 4 5 3
Figure 1. Plasmid Loss and Transformation Assay
Plasmid loss was assessed by plating cells and scoring for the GFP signal at various time points after induction of cas genes. Individual assays can be seen in
Figure S2. The bona fide target is abbreviated as WT.
(A) Example curves and CRISPR PCR of four different types of plasmid behaviors that were observed: rapid plasmid loss without spacer integration (D+P),
delayed plasmid loss and spacer integration (D+P+), strongly delayed plasmid loss and spacer integration (DP+), and no plasmid loss with no spacer integration
(DP).
(B) Summary of plasmid behavior of all mutants, showing timing of first plasmid loss and time of first observable spacer integration.
(C) The relative transformation efficiency is plotted for all mutant plasmids (fold change compared with co-transformed non-target plasmid, log2 scale). Bars are
color coded on the basis of plasmid behavior classification. Error bars represent SEM of triplicate experiments. The positions of mutations are indicated
schematically for each mutant (position 1, bottom; position 32, top). Open ovals represent mutations on positions 6, 12, 18, 24, and 30. Closed ovals represent
mutations outside of those positions (effective mutations). The amount of effective mutations is indicated above or below the schematic.
For a more detailed overview of the mutations, see Figure S1.(Datsenko et al., 2012; Savitskaya et al., 2013; Swarts et al.,
2012). Taken together, we found that priming is facilitated by
slow or delayed direct interference (D+P+), but that it does
not strictly require direct interference as exemplified by the
DP+ group.854 Molecular Cell 63, 852–864, September 1, 2016Moderate Direct Interference Activity Facilitates the
Priming Process
To verify that rapid plasmid loss indeed results from direct inter-
ference, we performed plasmid transformation assays of the
target plasmid set into E. coli KD263 and compared the
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Figure 2. Electrophoretic Mobility Shift
Assay and Cas3 Activity Assay
All mutants are classified according to previously
identified plasmid behavior. The mean and SD for
each group are indicated.
(A) Electrophoretic mobility shift assay (EMSA) of
the mutant plasmid set. The affinity ratio (ampli-
tude/Kd) is plotted for each mutant (see Table S3
for more details). The bona fide target is abbrevi-
ated as WT.
(B) Cas3 DNA degradation activity assay of mutant
plasmid set. The initial Cas3 DNA cleavage rate
(percentage per minute) is plotted for each mutant.
Individual gels for all activity assays can be found in
Figure S4.transformation efficiency to a co-transformed control plasmid
(Almendros and Mojica, 2015). Although the bona fide target
plasmid exhibited a relative transformation efficiency that was
512 times lower than the control plasmid (1/512), also mutants
with up to two effective mutations gave rise to strongly
decreased transformation efficiencies (1/16–1/512) (Figure 1C).
This means that these target variants still triggered an efficient
direct interference response. Triple mutants showed a range of
relative transformation efficiencies from full direct interference
(i.e. 1/512) to no direct interference (1), suggesting a dominant
role for the position of the mutations in the protospacer. Mutants
with four or five effective mutations transformed as efficiently as
the reference plasmid and displayed no direct interference.
When we mapped the classification of all the mutants onto the
relative transformation efficiency data, the same trend was
observed that target variants with the highest direct interference
showed no priming. Instead, intermediate levels of direct inter-
ference led to rapid spacer acquisition, while low levels or the
absence of direct interference led to delayed spacer acquisition.
This also confirms that late plasmid loss in the DP+ group is
indeed not caused by direct interference with the original spacer
but by primed spacer acquisition followed by direct interference.
Pairing at the Middle Position of Each Segment Is
Important for Direct Interference
The average number of effective mutations in a protospacer in-
creases gradually over the groups D+P, D+P+, DP+, and
DP (Figure S1). While D+P and D+P+ had either two or three
effective mutations, the DP+ mutants had three or four muta-
tions, and the DPmutants carried three or five effective muta-
tions in the protospacer. In order to quantify how significant the
shifts in the average number of mutations are, we used empirical
bootstrapping to test against the hypothesis that the classifica-
tion does not depend on the number of mutations. Our analysis
showed that the D+P and D+P+ groups have significantly fewer
mutations than would be expected if the classification did not
correlate with the number of mutations (>95% and >68% confi-
dence, respectively), while DP has significantly more muta-
tions (>95% confidence) (Figure S3A). We next looked in detailat the number of mutations in each segment and the position
of mutations in each five-nucleotide segment. As has been
observed for the seed sequence (Semenova et al., 2011; Wie-
denheft et al., 2011), this showed a significantly lower than
average number of mutations in segment 1 for D+P and D+P+
groups (both 95% confidence; Figure S3B). Surprisingly, the
analysis also revealed that groups showing direct interference
(D+P, D+P+) had no mutations at the third position of each
segment (significantly lower than expected, 95% confidence),
whereas DP+ and DP groups were enriched for mutations
at this position (>68% and >95% confidence, respectively; Fig-
ure S3C). This observation therefore suggests that pairing of
the middle nucleotide of the segment is somehow important
for direct interference. The third nucleotide of each segment
could represent a tipping point in the directional pairing of the
crRNA to the DNA. This may occur during canonical, PAM-
dependent target DNA binding, which leads to R-loop locking,
efficient Cas3 recruitment and target DNA degradation (Blosser
et al., 2015; Huo et al., 2014; Rutkauskas et al., 2015).
Cascade-Plasmid Binding Is Required for Interference
and Priming
To determine the biochemical basis of priming, we first asked the
question what determines whether a mutant target can prime or
not, and we hypothesized that the affinity of Cascade for a target
plasmid would determine its fate. To test this, we performed
plasmid-based mobility shift assays with purified Cascade com-
plexes (Ku¨nne et al., 2015). Although the bona fide target and
most of the mutant targets were bound to completion at
increasing Cascade concentrations, some mutant target plas-
mids were only partially bound (Table S3), as has been observed
before (Hochstrasser et al., 2014). By calculating an affinity ratio
(amplitude/Kd) and using it as an index for the binding strength,
we were able to directly compare the binding properties of all
target mutants (Figure 2A). The results show that the bona fide
target plasmid had the highest affinity ratio (0.31 nM1), while
the mutants cover a range of ratios ranging from very weak bind-
ing (>0.008 nM1) to almost the same levels as the bona fide
target (<0.1 nM1). DP mutants all cluster together with lowMolecular Cell 63, 852–864, September 1, 2016 855
ratios (<0.02 nM1), and five of eight show no measurable
Cascade binding. This suggests that a minimal level of target
plasmid binding by Cascade is required for both direct interfer-
ence and priming. However, the affinity ratio alone does not
predict direct interference and/or priming behavior of a target
plasmid.
Cas3 DNA Cleavage Activity Determines Plasmid Fate
Next, we analyzed if the catalytic rate of target DNA degradation
by Cas3 would be related to direct interference and priming.
Target DNA degradation is required for direct interference and
might be required for priming as well, since all cas genes are
required for priming in E. coli (Datsenko et al., 2012). To test
this, we performed Cas3 activity assays with the same panel of
target plasmids (Figures 2B and S4). This showed that there is
a strong dependence between plasmid fate and Cas3 activity.
Mutants capable of only direct interference (D+P) display
5–10 times higher activity than priming mutant classes (D+P+,
DP+), while stable mutants (DP) show the lowest Cas3 activ-
ity. Furthermore, D+P+ mutants show a slightly higher average
activity than DP+mutants. The difference between theCascade
affinity and the Cas3 activity plots shows that Cas3 activity is not
a simple reflection of Cascade affinity, but is likely influenced by
other factors such as conformational differences or the dy-
namics of Cascade binding. Taken together, there is a link be-
tween the Cas3 activity on a target and target plasmid fate.
Direct interference requires the highest Cas3 activity, while prim-
ing requires a level of target degradation and occurs at a broad
range of intermediate or low Cas3 activities. Finally, it is striking
that higher Cas3 activities seem to result in faster priming (D+P+
versus DP+), while very high Cas3 activities (D+P) do not lead
to priming.
Cas3 Produces Degradation Fragments of Near Spacer
Length
After establishing a connection between plasmid degradation
(direct interference) and primed spacer acquisition, we sought
to analyze whether the degradation fragments created by Cas3
could serve as spacer precursors. To that end, we performed
Cascade-mediated plasmid degradation assays with Cas3 and
plasmids containing the bona fide target or M4 mutant. Agarose
gel electrophoresis showed that both target plasmids were
degraded into similar-sized products smaller than 300 nt. Further
biochemical analysis of the products revealed that the products
were of double-stranded nature and contained phosphates at
their 50 end (Figures S5A and S5B). On the basis of the unidirec-
tional unwinding and single-stranded DNA cleavage mechanism
of Cas3 (Gong et al., 2014; Huo et al., 2014; Mulepati and Bailey,
2013; Sinkunas et al., 2013; Westra et al., 2012), we had ex-
pected to find single-stranded DNA. However, it appeared that
complementary fragments had re-annealed to form duplexes,
most likely generating annealed products with both 30 and 50
overhangs.
In order to determine the exact cleavage patterns of target
plasmids by Cas3, we isolated DNA cleavage products and
sequenced them using the Illumina MiSeq platform. Analysis of
the length of the DNA degradation products from the bona fide
and M4 target revealed that the majority of fragments from the856 Molecular Cell 63, 852–864, September 1, 2016target strand had a size of about 30–70 nt (Figures 3B and
S6A). The non-target strand displayed a shifted distribution,
with most fragments being 60–100 nt long. Instead of cleaving
the target DNA randomly, Cas3 produces fragments with a
distinct length profile. Furthermore, the length of the main frac-
tion, especially in the target strand, is close to the length of a
spacer molecule (i.e., 32 or 33 nucleotides), supporting the
idea that these fragments might be used as spacer precursor
molecules.
Cas3 Cleavage Is Sequence Specific for Thymine
Stretches
In order to determine whether Cas3 cleaves the target DNA in a
sequence-specific manner, we analyzed the region encompass-
ing the cleavage site. This revealed a preference for Cas3 to
cleave in thymine-rich sequences for both the bona fide and
the M4 target, preferably cleaving 30 of a T nucleotide (Figures
3C, 3D, and S6B). The same pattern was also observed for sin-
gle-stranded m13mp8 DNA cleaved in the absence of Cascade,
indicating that T-dependent cleavage specificity is an inherent
feature of the HD domain of Cas3. The cleavage specificity of
Cas3 leaves one or multiple T nucleotides on the 30 ends of
DNA degradation products. This enriches the 30 ends of the
fragments for NTT sequences, including the PAM sequence
CTT. A considerable proportion of degradation fragments there-
fore satisfies the requirement of Cas1-2 for having CTT se-
quences in the 30 ends of spacer precursors in order for these
to be correctly integrated into the CRISPR array (Shipman
et al., 2016; Wang et al., 2015). Interestingly, C/T-associated
cleavage has previously been shown for Streptococcus thermo-
philus Cas3 cleaving oligo nucleotides (Sinkunas et al., 2013),
suggesting that this cleavage specificity may be common for
HD-domains of Cas3 proteins.
Cas1-2 Integrate Cas3-Derived Degradation Fragments
To find out if Cas3 degradation products can indeed serve as
spacer precursors, we reconstituted spacer integration in vitro
using purified Cas proteins. Two types of spacer integration as-
sayswere performed (Figure 4A): the first assay used all Cas pro-
teins simultaneously (Cascade, Cas3, Cas1-2) to degrade a
target plasmid and integrate the resulting fragments into a
plasmid carrying a leader and single CRISPR repeat (pCRISPR).
The second assay used DNA degradation products from a sepa-
rate Cascade-Cas3 reaction. These products were incubated
with Cas1-2 and pCRISPR, as described (Nun˜ez et al., 2015b).
We noticed a pronounced Cas1-2-dependent shift of the degra-
dation fragments in the gel, suggesting the fragments are bound
by Cas1-2 (Figure 4B, left). Interestingly, when Cas1-2 was pre-
sent in the reaction we observed twice as much nicking of
plasmid pCRISPR, suggesting that half-site integration of DNA
fragments into pCRISPR had occurred (Figure 4B, right) (Nun˜ez
et al., 2015b). The same pCRISPR nicking activity was observed
using purified Cas3 degradation products (integration assay 2),
indicating that the integration reaction was not dependent on
Cascade or Cas3.
To verify that spacer half-site integration had taken place and
not just pCRISPR nicking, we gel-isolated the nicked pCRISPR
band for PCR analysis. Because we did not know the sequence
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Figure 3. Next-Generation Sequencing Analysis of Cas3 DNA Degradation Products
(A) Left: schematic of R-loop formed by binding of Cascade to dsDNA target. Right: schematic showing the four distinct Cas3 cleavage sites in dsDNA target.
(B) Length distribution of Cas3 DNA degradation fragments of M4 target.
(C) Heatmap of nucleotide frequencies around cleavage sites. The cleavage site is between positions1 and 1. Positions indicated in black are on the fragments;
positions indicated in gray are outside of fragments.
(D) Heatmap of dinucleotide frequencies around cleavage sites. Abundance of dinucleotides was measured in a shifting frame within four nucleotides around the
cleavage sites.
See also Figure S6.of the integrated fragments, we selected three primer pairs that
would amplify frequently incorporated spacers from the plasmid
in vivo (Fineran et al., 2014). Two of the three tested primers gave
a PCR product of the expected size, and we chose one of the
primers for more detailed analysis. It has previously been shown
that the first half-site integration may occur at the boundary of
the leader and repeat in the sense strand (i.e. site 1) or at the
penultimate base of the repeat in the antisense strand (i.e. site
2) (Nun˜ez et al., 2015b; Rollie et al., 2015). Furthermore, frag-
ments can be integrated in two different orientations. We per-
formed PCR amplification reactions to test for all four different
situations (Figure 5A). This showed that integration of Cas3-
derived degradation products occurs sequence specifically at
both site 1 and site 2 and in both orientations (Figure 5B).Integration of Fragments in theRepeat Is Nucleotide and
Position Specific
In order to obtain more insight into the accuracy of integration,
we sequenced 48 clones for each of the four primer sets. The re-
sults confirm that fragments from the target and non-target
strands are integrated at both site 1 and site 2 of the repeat. Inte-
gration is very specific to the correct positions in the repeat. At
site 1, 94% of the integrated fragments were coupled correctly
to the first nucleotide of the sense strand of the repeat, whereas
at site 2, 73% of integrated fragments were coupled correctly to
the penultimate nucleotide of the antisense strand of the repeat,
replacing the last nucleotide of the repeat in the process (Fig-
ure 6A). In line with previous findings (Nun˜ez et al., 2015b; Rollie
et al., 2015), both integration sites show a preference forMolecular Cell 63, 852–864, September 1, 2016 857
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Figure 4. In Vitro Spacer Acquisition Assays
(A) Illustration of the three types of assays per-
formed. In the oligo assay, pCRISPR is incubated
with Cas1-2 and a spacer oligo (BG7415/6), lead-
ing to half-site integration. In assay 1, pTarget and
pCRISPR are incubated with Cascade, Cas3, and
Cas1-2 for simultaneous degradation of pTarget
and half-site integration into pCRISPR. In assay 2,
pTarget is incubated with Cascade and Cas3, and
the resulting DNA degradation products are then
separately incubated with pCRISPR and Cas1-2.
(B) Gel electrophoresis of integration assay 1. The
bona fide target is abbreviated as WT. Left gel,
untreated; right gel, proteinase K treated. Cas1-2
presence causes upward shift of DNA. Original
plasmids are supercoiled (SC); half-site integration
causes nicking of pCRISPR, resulting in the open
circular conformation (OC).coupling incoming C nucleotides: 49% and 55% for site 1 and
site 2, respectively (Figure 6A). Considering that Cas3 DNA
degradation fragments have T nucleotides on their 30 ends, this
suggests that precursors have been pre-processed by Cas1-2
before integration, as has been demonstrated for artificial
substrates (Wang et al., 2015). The majority of the integration
amplicons had a length of only 20–40 nucleotides (Figure 6B),
indicating that the integration reaction prefers short to long
substrates. Altogether, we show that the integration of PAM-
containing spacers in the repeat during priming is enhanced by
the combined sequence specificities of two Cas enzymes: (1)858 Molecular Cell 63, 852–864, September 1, 2016Cas3, which leaves thymines in the
30-end of DNA fragments, enriching the
fragment ends for CTT, and (2) Cas1-2,
which prefer CTT-carrying substrates
and process and couple the 30 cytosine
specifically to both integration sites of
the repeat.
DISCUSSION
A remaining gap in our understanding of
type I CRISPR-Cas mechanisms is how
new spacers are selected and processed
before being incorporated into the
CRISPR array. In this work we demon-
strate that Cas3 produces spacer precur-
sors for primed adaptation of the CRISPR
array. Cas3 DNA degradation fragments
fulfill all criteria for spacer precursors that
can be deduced from recent studies of
the Cas1-2 complex (Figure 7). Ideal
spacer precursors in E. coli are partially
double-stranded duplexes of at least 35
nucleotides containing splayed single-
stranded 30 ends with a CTT PAM
sequence on one of the 30 overhangs (Nu-
n˜ez et al., 2015a; Rollie et al., 2015;
Shipman et al., 2016; Wang et al., 2015).We have shown that Cas3 DNA degradation products are mainly
double-stranded in vitro. This is most likely due to re-annealing of
the single-stranded products that are produced by the nuclease-
helicase activity of Cas3. It is possible that in vivo, other proteins
are involved in the formation of duplexes after degradation. In
fact, it has been shown that Cas1 from Sulfolobus solfataricus
can facilitate the annealing of oligonucleotides (Han and Krauss,
2009). These re-annealed duplexes likely contain a mix of 30
and 50 overhangs, because the two DNA strands of the target
are degraded independently. This also results in slightly shorter
fragments for the target strand. Despite these differences in
B
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(A) Illustration of the half-site integration PCR.
Primer sets are chosen to show integration into site
1 (leader-proximal repeat end) and site 2 (leader
distal repeat end) and to see both possible orien-
tations of the integrated spacer. Primer sequences
were chosen on the basis of frequently incorpo-
rated spacers (hot spots) in vivo (Fineran et al.,
2014).
(B) Gel electrophoresis of half-site integration PCR
on the basis of integration assay 2 (left) and oligo
assay (right). PCR products representing in-
tegrations are indicated with an arrow. PCR prod-
ucts were specific to reactions containing all
components. Lower running PCR products are
primer dimers (verified by sequencing).fragment size, both strands are cleaved by Cas3 with the same
specificity, enriching the 30 ends of the fragments for stretches
of thymines. Contrary to the CTT requirements for spacer integra-
tion, it is known that Cascade tolerates five different PAM se-
quences (i.e. CTT, CTA, CCT, CTC, and CAT) for direct interfer-
ence (Fineran et al., 2014; Leenay et al., 2016). However, the
vast majority of new spacers (97%) resulting from primed acqui-
sition carry CTT PAM sequences (Shmakov et al., 2014). This
further supports the idea that spacer precursors with CTT-ends
are selected non-randomly by the Cas1-2 complex from pools
of Cas3 breakdown fragments and further trimmed to a 30 C
(Wanget al., 2015). These are then coupled to the repeat by nucle-
ophilic attack of the 30-OH (Nun˜ez et al., 2014; Rollie et al., 2015).
The T-dependent target DNA cleavage specificity of Cas3 further
enhances the production of precursors that fit the requirements of
new spacers by creating a pool of DNA fragments with the correct
size and correct 30 ends. The interference phase of CRISPR im-
munity is therefore effectively coupled to the adaptation phase,
providing positive feedback about the presence of an invader.
It was previously reported that a dinucleotide motif (AA) at the
30 end of a spacer increases the efficiency of naive spacer acqui-
sition (Yosef et al., 2013). We did not observe this motif at the ex-
pected distance from the end in the Cas3 DNA degradation frag-
ments, suggesting that Cas3 does not take the AA motif into
account when generating spacer precursors.MoleculaWe found that the integration reaction
is very precise for the two correct integra-
tion sites in the repeat (site 1 and site 2),
and we observed that the integrated frag-
ments most often were the result of a 30
cytosine coupling reaction. In vivo, how-
ever, only the integration of a CTT-con-
taining fragment at site 2 would lead to
a functional spacer targeting a proto-
spacer with PAM (Figure 7), while CTT
integration at site 1 would result in ‘‘flip-
ped’’ spacers (Shmakov et al., 2014).
Using a selective PCR strategy, we de-
tected primed spacer acquisition events
at both integration sites, and we identi-
fied that DNA fragments are integratedin both orientations. In type I-E CRISPR-Cas systems, primed
spacer acquisitions display a typical 9:1 strand bias for the
acquisition of spacers targeting the same strand of DNA as
the spacer causing priming (Datsenko et al., 2012; Swarts
et al., 2012). This suggests that in vivo, other factors might be
involved in further increasing the accuracy of functional spacer
integration. This includes the formation of supercomplexes be-
tween various Cas proteins (i.e. Cascade, Cas3, Cas1-2) (Pla-
gens et al., 2012; Redding et al., 2015; Richter et al., 2014)
and the involvement of non-Cas host proteins such as PriA,
RecG, and IHF (Ivancic-Bace et al., 2015; Nun˜ez et al., 2016).
IHF ensures that the first integration event takes place at the
leader-proximal end of the repeat (site 1) and might be involved
in ensuring that the PAM cytosine gets integrated at the leader-
distal end (site 2). Supercomplex formation during precursor
generation may lead to the selection of fragments from the
target strand containing a CTT PAM at the 30 end. Although
the length of the observed integration amplicons is centered
around 20–40 nt, we also find amplicons of up to 100 nt. In vivo,
E. coli integrates fragments of 33 nt in length. We speculate
that trimming of the precursor to 33 nt in length occurs after
half-site integration and before formation of the stable integra-
tion intermediate (Figure 7). Despite the mechanisms that lower
erroneous integration of new spacers, it is likely that natural
selection of functional spacers in vivo also plays a role in ther Cell 63, 852–864, September 1, 2016 859
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(A) Frequencies of exact integration locations for
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gives the backbone nucleotide to which the spacer
is coupled. Frequencies of coupled spacer nucle-
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(B) Top: schematic of integrated fragment and
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the integration amplicon for site 1 and site 2.spacers that end up being part of the first population of bacteria
following a priming event.
It was surprising that the bona fide target and several
D+P mutants did not show priming despite providing Cas3
degradation products. Furthermore, the degradation fragments
of the bona fide target (D+P) were very similar to the fragments
of the M4 target (D+P+), which cannot explain the difference in
priming behavior. We propose that these targets are degraded
and cured from the cell too rapidly, giving the acquisition ma-
chinery insufficient time to generate new spacers. However, a
low level of spacer integration might be taking place at undetect-
able levels even for the bona fide target, as has been observed
previously (Swarts et al., 2012; Xue et al., 2015). In this case, cells
with additional spacers do not have a selective growth advan-
tage over cells without new spacers, as the plasmid is already
effectively cleared from cells without new spacers. Mutant tar-
gets with intermediate levels of direct interference, however,
are replicated and subject to interference over a longer time
period, thereby providing more precursors, more time for spacer
acquisition to occur, and therefore a greater selective growth
advantage. Low levels of direct interference lead to a slow prim-
ing response because of the scarcity of spacer precursor mole-
cules. While this paper was under review, another study showed
that perfectly matching protospacers with canonical PAMs can
indeed stimulate priming and that plasmid targeting is the stim-
ulating factor (Semenova et al., 2016). In line with our findings,860 Molecular Cell 63, 852–864, September 1, 2016the authors further propose that priming
is usually not observed with fully matching
protospacers because these targets are
degraded too rapidly.
Cut-Paste Spacer Acquisition
We have shown that priming reuses target
DNA breakdown products as precursors
for new spacers, providing support for a
cut-and-paste mechanism of spacer se-
lection (Wang et al., 2015). Compatible
models have recently been proposed for
naive spacer acquisition (Levy et al.,
2015). It was shown that CRISPR adapta-
tion is linked to dsDNA breaks that form at
stalled DNA replication forks. Invading ge-
netic elements often go through a phase
of active DNA replication when they enter
a host cell, and a replication-dependentmechanism therefore helps the host primarily select spacers
from the invading element. The RecBCD complex is key in this
process as it repairs double-stranded breaks by first chewing
back the ends of the DNA, creating fragments of tens to
thousands of nucleotides (Amitai and Sorek, 2016). These frag-
ments are thought to reanneal and serve as precursors for new
spacers. Other studies have shown the direct involvement of
crRNA-effector complexes in spacer selection. In the type I-F
CRISPR-Cas system of Pseudomonas aeruginosa, the Csy com-
plex is required for naive spacer acquisition (Vorontsova et al.,
2015). Also, Cas9 in type II systems has a direct role in spacer
acquisition (Heler et al., 2015; Wei et al., 2015). Both systems
incorporate spacers very specifically from canonical PAM sites,
suggesting that the Csy complex and Cas9 are directly involved
in PAM recognition during spacer sampling.
Mutations in the Protospacer
In this study, we have focused on the effect of mutations in the
protospacer on direct interference and priming, while maintain-
ing the dominant interference permissive PAM CTT. Apart from
underscoring the importance of the number of mutations and ex-
istence of a seed sequence (Semenova et al., 2011; Ku¨nne, et al.,
2014; Wiedenheft et al., 2011; Xue et al., 2015), we uncover that
for direct interference, pairing of the middle nucleotide in each
five-nucleotide segment of the protospacer is disproportionately
important and may represent a tipping point in the binding of a
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Cleavage of a targeted plasmid during direct
interference by Cascade and Cas3. Cleavage
products are near spacer length and reanneal to
form duplexes with 50 and/or 30 overhangs. The
fragments are enriched for NTT sequences on
their 30 ends. A fraction of the duplexes fulfils
spacer precursor requirements: 30 overhangs,
CTT at one 30 end, and a 33 nt distance between
the C and the opposite 30 overhang. Cas1-2
binds spacer precursors with a preference for
ideal duplexes as described above (Nun˜ez et al.,
2015a; Wang et al., 2015). The precursor is
processed by Cas1-2 to a length of 33 nt with 30
cytosine. In parallel to processing, 30 ends of the
precursor perform a Cas1-2 catalyzed nucleo-
philic attack on the two integration sites of the
repeat (Nun˜ez et al., 2015b; Rollie et al., 2015).
Integration at the leader-repeat junction occurs
first (Nun˜ez et al., 2016); subsequently, the PAM-
derived 30 cytosine is integrated to ensure cor-
rect orientation and production of a functional
spacer. A stable spacer integration intermediate
is formed (Arslan et al., 2014). The gaps are filled
in and repaired by the endogenous DNA repair
systems, including DNA polymerase I (Ivancic-
Bace et al., 2015).target. None of the mutants showing direct interference carried
mutations at these middle positions. Also, in a previously ob-
tained list of approximately 3,300 triple mutants showing direct
interference (Fineran et al., 2014), mutations at this position
were underrepresented (Figure S3D). This suggests that pairing
at the middle position of each segment may be important for
continuation of the directional zipping process. This process
starts at the PAM and leads to the formation of a canonical
locked R-loop, which is required for Cas3 recruitment and target
DNA degradation (Blosser et al., 2015; Redding et al., 2015; Rut-
kauskas et al., 2015; Szczelkun et al., 2014). We stress that we
have used variants with CTT PAMs only, which can be engaged
by Cascade in the canonical PAM-dependent binding modeMolecula(Blosser et al., 2015; Hayes et al., 2016;
Redding et al., 2015; Rutkauskas et al.,
2015) and can also trigger priming. It has
become clear, however, that targets with
mutations in the PAM display a broad
spectrum of distinct characteristics de-
pending on the chosen PAM, including a
range of efficiencies of direct interference
(Westra et al., 2013) and the reluctance to
trigger efficient Cas3 target DNA degra-
dation (Blosser et al., 2015; Hochstrasser
et al., 2014; Mulepati and Bailey, 2013;
Redding et al., 2015; Rutkauskas et al.,
2015; Xue et al., 2015). In many cases,
these PAMs still support the priming pro-
cess (Datsenko et al., 2012; Fineran
et al., 2014; Xue et al., 2015). Targets
with highly disfavored PAMs (Hayes
et al., 2016) are likely engaged in thenon-canonical PAM-independent binding mode (Blosser et al.,
2015) and may require recruitment and translocation events of
Cas1-2 and Cas3 proteins to initiate the target degradation
needed to acquire new spacers.
Conclusions
The findings presented here showcase the intricate PAM inter-
play of all Cas proteins in type I systems to update the CRISPR
memory when receiving positive feedback about the presence
of an invader. The robustness of priming is achieved by three
components that co-evolved to work with PAM sequences:
Cas3, producing spacer precursors enriched for correct PAM
ends, Cas1-2 selecting PAM-compliant spacer precursors, andr Cell 63, 852–864, September 1, 2016 861
Cascade efficiently recognizing targets with PAMs. This process
stimulates the buildup of multiple spacers against an invader,
preventing the formation of escape mutants (Datsenko et al.,
2012; Richter et al., 2014; Swarts et al., 2012). When the original
spacer triggers sufficiently strong interference, priming acquisi-
tion does not frequently occur. This prevents the unnecessary
buildup of spacers and keeps the CRISPR array from getting
too long. Any subsequent reduction in effectivity of the immune
response by further mutations of the invader will in turn allow
priming acquisition, restoring immunity.
EXPERIMENTAL PROCEDURES
Transformation and Plasmid Loss Assay
Both assays were carried out in E. coli KD263 cells, which have inducible cas
gene expression. Expression was induced with 0.2% L-arabinose and 0.5 mM
isopropyl b-D-1-thiogalactopyranoside where appropriate. Briefly, transfor-
mation efficiency was assessed by comparing colony-forming units (CFUs)
of target plasmid transformations to CFUs of a control plasmid. Plasmid loss
was assessed by loss of fluorescence in colonies, and spacer acquisition
was determined by PCR of the CRISPR array. For details, see ‘‘Transformation
Assay’’ and ‘‘Plasmid Loss Assay’’ in Supplemental Experimental Procedures.
Protein Purification
All proteins were expressed in Bl21-AI cells. Cascade was purified as
described previously (Jore et al., 2011). MBP-Cas3 was purified as described
by Mulepati and Bailey (2013). The Cas1-2 complex was purified similarly to
Cascade using affinity chromatography (see ‘‘Protein Purification’’ in Supple-
mental Experimental Procedures).
Electrophoretic Mobility Shift Assays
Purified Cascade complex was incubated with plasmid at a range of molar ra-
tios (1:1–100:1, Cascade:DNA). After electrophoresis, protein-bound and un-
bound DNA was quantified and the affinity calculated. For details, see
‘‘EMSA Assays’’ in Supplemental Experimental Procedures.
Cas3 DNA Degradation Assays
Cas3 DNA degradation activity was routinely tested by incubating 500 nM
Cas3 with 4 nMM13mp8 single-stranded circular DNA. Plasmid-based assays
were performed by incubating 70 nM Cas3 with 70 nM Cascade, 3.5 nM
plasmid DNA. For details and activity quantification, see ‘‘Cas3 DNA Degrada-
tion Assays’’ in Supplemental Experimental Procedures.
Statistical Testing
We used a version of the empirical bootstrap method (Dekking, 2005) to test
our data against the null hypothesis that observed behaviors (D±P±) do not
correlate with a particular sequence property. For details, see ‘‘Statistical
Testing against the Null Hypothesis’’ in Supplemental Experimental
Procedures.
In Vitro Acquisition Assays
Two types of assays were performed. First, Cas3 plasmid DNA degradation
assays were carried out as described above, and the reaction products
were incubated with Cas1-2 and pWUR869 in buffer R for 60 min. Second,
target plasmid, Cascade, Cas3, Cas1-2, and pWUR869 were incubated in
buffer R for 60 min. For details, see Figure 5A and ‘‘In Vitro Acquisition Assay’’
in Supplemental Experimental Procedures.
Next-Generation Sequencing
Plasmid degradation assays were performed as previously described. Three
different targets were chosen: bona fide target plasmid (pWUR836) or M4
target plasmid (pWUR853) with 0.13 mM ATP and the m13mp8 assay as
described above. Degradation fragments were processed for Illumina MiSeq
sequencing (see ‘‘NGS Library Construction’’ in Supplemental Experimental862 Molecular Cell 63, 852–864, September 1, 2016Procedures). For details on data processing, see ‘‘NGS Data Analysis’’ in Sup-
plemental Experimental Procedures.ACCESSION NUMBERS
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